Outset Medical Q1 revenue down 6% to $27.9M; gross margin expands to 43.4%

Outset Medical, Inc.

2026-Q1 EPS reported -$1.03 revenue$27,863,000

Revenue $27.9M (-6% YoY); recurring revenue $22.5M roughly flat.
Gross margin 43.4% (up from 37.2% YoY); product gross margin record 52.4%, service margin record 25.5%.
Net loss narrowed to $19.0M from $25.8M; cash $161M at quarter end.
Reiterated FY 2026 revenue guidance $125-130M (5-9% growth) and non-GAAP gross margin low-to-mid 40%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Outset Medical, Inc. reported the first quarter ended March 31, 2026 results: revenue $27.9 million, net income Net loss was $19.0 million. Guidance reaffirmed.

Period: the first quarter ended March 31, 2026
Revenue: $27.9 million
Net income: Net loss was $19.0 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Net revenue totaled $27.9 million, a decrease of 6% compared to $29.8 million in the first quarter of 2025.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Outset Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-211980

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.